Zapata LB, Steenland MW, Brahmi D, Marchbanks PA, Curtis KM. Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review. Contraception. 2013;87(5):685–700. doi:10.1016/j. contraception.2012.08.035.
Wilcox AJ, Dunson DB, Weinberg CR, Trussell J, Baird DD. Likelihood of conception with a single act of intercourse: providing benchmark rates for assessment of post-coital contraceptives. Contraception. 2001;63(4):211–5.
Wilcox AJ, Dunson D, Baird DD. The timing of the “fertile window” in the menstrual cycle: day specific estimates from a prospective study. BMJ. 2000;321(7271):1259–62.
Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM. The effect of follow-up visits or contacts after contraceptive initiation on method continuation and correct use. Contraception. 2013;87(5):625–30. doi:10.1016/j. contraception.2012.09.018.
Steenland MW, Zapata LB, Brahmi D, Marchbanks P, Curtis KM. Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. Contraception. 2013;87(5):611–24. doi:10.1016/j.contraception.
Nisenbaum MG, Melo NR, Giribela CR, Morais TL, Guerra GM, de Angelis K et al. Effects of a contraceptive containing drospirenone and ethinyl estradiol on blood pressure and autonomic tone: a prospective controlled clinical trial. Eur J Obstet Gynecol
Kapp N, Tilley IB, Curtis KM. The effects of hormonal contraceptive use among women with viral hepatitis or cirrhosis of the liver: a systematic review. Contraception. 2009;80(4):381–6.
Kapp N, Curtis KM. Hormonal contraceptive use among women with liver tumors: a systematic review. Contraception. 2009;80(4):387–90.
Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception. 2010;82(1):10–6.
Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol. 2011;117(3):657–62.
Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol. 2011;117(3):691– 703.
Gaffield ME, Kapp N, Ravi A. Use of combined oral contraceptives post abortion. Contraception. 2009;80(4):355–62.
Gaffield ME, Culwell KR, Ravi A. Oral contraceptives and family history of breast cancer. Contraception. 2009;80(4):372–80.
Brahmi D, Curtis KM. When can a woman start combined hormonal contraceptives (CHCs)? A systematic review. Contraception. 2013;87(5):524–38. doi:10.1016/j. contraception.2012.09.010.
Berenson AB, Rahman M. A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms. Contraception. 2012;86(6):716–24. doi:10.1016/j.contraception.2012.06.007.
The WHO Medical Eligibility Criteria Wheel for Contraceptive Use (2015)
A tool that makes it easy to identify medical eligibility for use of family planning methods.
The Selected Practice Recommendations for Contraceptive Use (3rd Edition 2016).
This resource provides guidance on how to use contraceptive methods safely and effectively, once they are deemed to be medically appropriate.
The Medical Eligibility Criteria for Contraceptive Use (5th edition 2015).
This resource provides guidance on whether people with certain medical conditions can safely and effectively use specific contraceptive methods.
Family Planning: A Global Handbook for Providers (2022 update).
This book serves as a quick-reference resource for all level of health care workers. It provides practical guidance on delivering family planning methods appropriately and effectively.
